VTX958

· Ventyx Biosciences, Inc

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for VTX958, covering 2024-09-19 to 2025-07-03. Get the full timeline:

Most recent: Clinical Trial Update: VTX958 for the Treatment of Moderately to Severely Active Crohn's Disease [Phase 2]